Font Size
A
A
A

Obesity (cont.)

Where Can People Find More Information on Obesity?

American Heart Association

American Society for Bariatric Surgery

Association for Coordination and Research in Obesity and Nutrition: This European group provides information on obesity research in Europe. The web site has information in English and French.

Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Nutrition and Physical Activity, Overweight and Obesity

National Institutes of Health, Health Information: Weight Loss and Control

National Obesity Education Initiative, Aim for a Healthy Weight, Information for Patients and the Public

Obesity Law and Advocacy Center: This is a law firm in San Diego, Calif., that specializes in legal issues in obesity.

REFERENCES:

Allison, D.B., et al. "Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)." Obesity 20.2 Feb. 2012: 330-342.

Apovian, C.M., L.J. Aronne, and D.H. Bessesen, et al. "Pharmacological management of obesity: an endocrine society clinical practice guideline." J Clin Endocrinol Metab 100 (2015): 342.

Douketis, J.D., C. Macie, L. Thabane, and D.F. Williamson. "Systematic Review of Long-Term Weight Loss Studies in Obese Adults: Clinical Significance and Applicability to Clinical Practice." Int J Obesity (2005): 1153-1167.

Ebbeling, C.B., and D.S. Ludwig. "Tracking Pediatric Obesity, an Index of Uncertainty?" JAMA (2008): 2442-2443.

Fidler, M.C., et al. "A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial." J Clin Endocrinol Metab 96.10 Oct. 2011: 3067-3077.

Flegal, K.M., M.D. Carroll, C.L. Ogden, and L.R. Curtin. "Prevalence and Trends in Obesity Among U.S. Adults, 1999-2008." JAMA 303.3 (2010): 235–241.

Gadde, K.M., et al. "Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial." Lancet 377.9774 Apr. 16, 2011: 1341-1352.

Ikramuddin, S., R.P. Blackstone, A. Brancatisano, et al. "Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial." JAMA 312 (2014): 915.

Jensen, M.D., D.H. Ryan, C.M. Apovian, et al. "2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society." Circulation 129 (2014): S102.

Kernan, W.N., C.M. Viscoli, L.M. Brass, et al. "Phenylpropanolamine and the Risk of Hemorrhagic Stroke." N Engl J Med 343 (2000): 1826.

Kim, G.W., J.E. Lin, E.S. Blomain, and S.A. Waldman. "Antiobesity pharmacotherapy: new drugs and emerging targets." Clin Pharmacol Ther 95 (2014): 1.

Klein, S., et al. "Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease." N Engl J Med 250.25 (2004): 2549-2557.

Klein, S., et al. "Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease: A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation." Circulation 110.18 (2004): 2952-2967.

Kral, J.G., W. Paez, and B.M. Wolfe. "Vagal nerve function in obesity: therapeutic implications." World J Surg 33 (2009): 1995.

Li, Z., et al. "Meta-analysis: Pharmacologic Treatment on Obesity." Ann Intern Med 142.7 (2005): 532-546.

O'Brien, P.E., et al. "Treatment of Mild to Moderate Obesity With Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program: A Randomized Trial." Ann Int Med 144.9 (2006): 625-633.

Ogden, C.L., M.D. Carroll, and K.M. Flegal. "High Body Mass Index for Age Among US Children and Adolescents, 2003-2006." JAMA 299.20 (2008): 2401-2405.

Padwal, R., S.K. Li, and D.C. Lau. "Long-term Pharmacotherapy for Obesity and Overweight." Cochrane Database Syst Rev (2004).

Poirier, P., et al. "Obesity and Cardiovascular Disease: Pathophysiology, Evaluation and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical activity, and Metabolism." Circulation 113.6 (2006): 898-918.

Sjostrom, L., et al. "Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric Surgery." N Engl J Med (2004): 2683-2693.

Whitmer, R.A., et al. "Central Obesity and Increased Risk of Dementia More Than Three Decades Later." Neurology (2008).


Medically Reviewed by a Doctor on 4/7/2016
Medical Author:

Must Read Articles Related to Obesity

Medication in the Treatment of Obesity
Medication in the Treatment of Obesity Obesity is defined as a body mass index (BMI) of 30 or higher. Medications used to treat obesity work by suppressing the appetite. Prescription weight-loss medi...learn more >>
Obesity (Bariatric Surgery)
Surgery in the Treatment of Obesity A person is considered obese when they have a BMI...learn more >>
Weight Loss
Weight Loss and Control Obesity is simply the accumulation of excess body fat. It is much more than that, however. Obesity is a chronic (long-term) disease that is very difficult to tr...learn more >>

Patient Comments & Reviews

The eMedicineHealth doctors ask about Obesity:

Obesity In Children - Causes

What is/was the cause of your obesity?

Obesity - Cause

What is/was the cause of your obesity?

Obesity - Effective Treatments

What kinds of treatments have been effective for your obesity?


Read What Your Physician is Reading on Medscape

Obesity »

Obesity is a substantialpublic-health crisis in the United States and in the rest of the developed world.

Read More on Medscape Reference »


Medical Dictionary